Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics.
about
Molecular Genetic Markers in Acute Myeloid LeukemiaNext-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutationsWT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferationDNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategiesAcquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation.Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoringMutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutationsIntegrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolution.Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable.The Role of Additional Sex Combs-Like Proteins in Cancer.Prevalence and Prognostic Value of IDH1 R132 Mutation in Newly Diagnosed AML Egyptian Patients with Normal Karyotype.Dysregulation of TET2 in hematologic malignancies.Molecular landscape in acute myeloid leukemia: where do we stand in 2016Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid Leukemia.Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34⁺ progenitor cells.ASXL1 mutations are infrequent in young patients with primary acute myeloid leukemia and their detection has a limited role in therapeutic risk stratification.FLT3-ITD, NPM1, and DNMT3A Gene Mutations and Risk Factors in Normal Karyotype Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients in Upper Northern ThailandFrequency and Clinicopathologic Features of RUNX1 Mutations in Patients With Acute Myeloid Leukemia Not Otherwise Specified.Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.Adults with germline CBL mutation complicated with juvenile myelomonocytic leukemia at infancy.Synchronous Occurrence of Mycosis Fungoides, Diffuse Large B Cell Lymphoma and Acute Myeloid Leukemia.Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML.Monosomal karyotype in acute myeloid leukemia and the role of allogeneic hematopoietic cell transplantation.Preferential occurrence of spliceosome mutations in acute myeloid leukemia with preceding myelodysplastic syndrome and/or myelodysplasia morphology.Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm
P2860
Q26799606-7F08B05B-689E-446C-AF91-19FDF7256512Q27853094-491A3A45-ADF2-4FEC-9212-21C99AA86AEEQ28255707-A9C6AC9E-475C-48DA-8145-2B910965172BQ34661033-CF82CE6A-3F23-4B9A-9891-F6D218E8F549Q37552020-FFCF0D48-43F8-4EBD-BB87-124FF19BDE87Q37618897-7DA8DF73-9740-4EF1-AA15-6D04B4AA3CADQ37688148-8AD64641-8992-4F5D-BF1F-58B7C4F7BBBCQ38218055-4CDC5049-475A-4A87-B5C0-C91BFB734688Q38248429-A38E1F2E-6ABD-4555-90E2-19B61698B94BQ38928350-F4313090-8BDC-40A5-9156-05A0DC6DFCC8Q38963204-8C40CA67-C0ED-4361-BB0A-389D91243700Q39009790-7628267B-311B-43AE-AF06-CD9D98226E03Q39116878-B77F39CC-545D-4A41-B035-8A81609B41E9Q39135620-FFACE4A9-D0C7-4EBF-8981-142D7C1B3985Q43767798-8EA914DA-5301-4E4A-920D-C77D235C1C68Q44113808-9AD2C902-6548-44AF-97D2-4E493FE12097Q47418833-8823E460-1895-4530-97CB-9564FAE23D78Q47777732-F4FFD5AA-635C-4B00-B87D-2A7319045EC2Q47929356-ECD3CFD4-AD51-4DD5-9737-97323EFDA864Q48230865-5F870303-D207-4B3F-BA1A-1123A56FC3E3Q50101634-E8871913-747D-4E80-BC93-EB51CF9CCDF9Q50900611-029F0684-42A7-4D12-B2AE-E5B505DF6802Q53241862-29C2E621-2BC5-4490-81EC-9C833F29163BQ53246202-76071CED-5970-41A9-9130-97FE50311D07Q58010082-11BDF670-AE4A-49A4-A7D7-9EF36567B525
P2860
Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Mutation patterns of 16 genes ...... AML) with normal cytogenetics.
@ast
Mutation patterns of 16 genes ...... AML) with normal cytogenetics.
@en
Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia
@nl
type
label
Mutation patterns of 16 genes ...... AML) with normal cytogenetics.
@ast
Mutation patterns of 16 genes ...... AML) with normal cytogenetics.
@en
Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia
@nl
prefLabel
Mutation patterns of 16 genes ...... AML) with normal cytogenetics.
@ast
Mutation patterns of 16 genes ...... AML) with normal cytogenetics.
@en
Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia
@nl
P2093
P2860
P50
P1433
P1476
Mutation patterns of 16 genes ...... AML) with normal cytogenetics.
@en
P2093
Carwyn Davies
Cristina Pérez
Emma-Jane McDonald
James S Wainscoat
María Dolores Odero
María José Calasanz
María José Larrayoz
Sally Killick
Toshinori Kondo
P2860
P304
P356
10.1371/JOURNAL.PONE.0042334
P407
P50
P577
2012-08-09T00:00:00Z